at://
/
app.bsky.feed.post
/
3mo4majspa52l
sign in
All
4
Record
2
Post
1
PostEmbed
1
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
Dana-Farber research supports FDA approval of pembrolizumab-belzutifan combination for higher-risk clear cell kidney cancer after surgery. Research led by @drchoueiri.bsky.social of @danafarber.bsky.social. Read more here: bit.ly/447yerK
5d
Dana-Farber News
